StockData
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ) shareholders

JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30121% above fair value
$240.71+0.94 (+0.39%)

Close on Nov 17, 2026Market cap $15.63BP/E 78.4Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
99.2%
64M of 65M shares
Institutional holders
643
133 new, 56 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 66 sales
Net sold $86.70M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.5,872,1239.50%13G (passive) amendmentSep 30, 2024
Abigail P. Johnson
Joint filing with FMR LLC (8.60%)
5,601,9078.60%13G (passive) amendmentSep 30, 2026
FMR LLC
Joint filing with Abigail P. Johnson (7.40%)
4,675,4597.40%13G (passive)Jun 30, 2026
Vanguard Capital Management3,103,5225.04%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of JAZZValueChange% of portfolio
BlackRock, Inc.5,968,6039.19%$1.44B+376,9030.02%
FMR LLC4,609,3267.10%$1.11B+2,333,5640.05%
Vanguard Portfolio Management LLC3,036,2134.68%$731.64M+52,9710.03%
Vanguard Capital Management LLC2,729,6504.20%$657.76M+81,3170.01%
Capital World Investors2,697,6104.16%$650.04M+24,2340.08%
Lsv Asset Management2,275,1453.50%$548.24M−111,6950.99%
Franklin Resources Inc2,040,2503.14%$491.64M+81,3100.11%
State Street Corp1,999,8163.08%$481.90M+108,1700.01%
Dimensional Fund Advisors LP1,713,5922.64%$412.91M−181,6230.07%
Fuller & Thaler Asset Management, Inc.1,638,5442.52%$394.84M−37,5981.08%
Bank of New York Mellon Corp1,578,0132.43%$380.25M−101,3580.06%
Aqr Capital Management LLC1,522,5682.35%$359.94M+184,1100.13%
Geode Capital Management, LLC1,483,0312.28%$357.44M+245,4140.02%
Ameriprise Financial Inc1,215,5231.87%$292.90M−392,9530.06%
JPMorgan Chase & Co1,160,7861.79%$276.63M−43,5670.02%
Bank Of America Corp /De/1,136,0911.75%$273.76M+121,2910.02%
Citadel Advisors LLC1,006,6761.55%$242.58M−252,7680.03%
Swedbank AB968,0921.49%$233.28M−24,0160.20%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.799,2971.23%$192.61M−85,9040.19%
Millennium Management LLC763,8801.18%$184.07M−498,6310.07%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202664364M99.2%133 / 241188 / 569M10M
Q1 202657565M100.0%92 / 226163 / 7915M7M
Q4 202557463M97.7%129 / 179195 / 5110M10M
Q3 202550363M96.5%61 / 163200 / 537M6M
Q2 202550262M95.8%60 / 188179 / 1039M6M
Q1 202555059M90.9%100 / 218157 / 528M7M
Q4 202450959M91.2%92 / 169173 / 566M6M
Q3 202447859M91.4%77 / 164159 / 5012M6M
Q2 202445659M91.0%62 / 160165 / 838M10M
Q1 202448161M94.5%53 / 184160 / 679M7M
Q4 202350059M91.4%79 / 166179 / 589M6M
Q3 202348557M87.2%62 / 163178 / 434M4M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

209 funds held JAZZ in Q2 2026, 63% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of JAZZValue% of fundAs of
Vanguard Total Stock Market Index Fund1,892,5222.92%$456.04M0.02%Jun 30, 2026
Fullerthaler Behavioral Small Cap Equity1,561,5632.41%$376.29M2.97%Jun 30, 2026
Vanguard Small-Cap Index Fund1,366,7672.11%$329.35M0.17%Jun 30, 2026
Vanguard Small-Cap Value Index Fund865,9371.33%$208.66M0.31%Jun 30, 2026
Vanguard Extended Market Index Fund719,2111.11%$173.31M0.18%Jun 30, 2026
VictoryShares Free Cash Flow ETF469,8580.72%$113.22M1.46%Jun 30, 2026
Dimensional U.S. Small Cap ETF168,5740.26%$42.63M0.28%Jul 31, 2026
Vanguard Health Care Index Fund164,2060.25%$38.83M0.20%May 31, 2026
iShares U.S. Pharmaceuticals ETF163,0230.25%$39.28M3.45%Jun 30, 2026
Avantis U.S. Large Cap Value ETF154,7180.24%$36.59M0.28%May 31, 2026
Pear tree polaris foreign value fund150,3060.23%$36.22M2.42%Jun 30, 2026
Dimensional U.S. Core Equity 2 ETF147,0120.23%$37.17M0.08%Jul 31, 2026
Vanguard Strategic Equity Fund133,8190.21%$32.25M0.27%Jun 30, 2026
iShares Russell 1000 Value ETF133,4450.21%$32.16M0.04%Jun 30, 2026
Nuveen Mid Cap Value Fund127,8880.20%$32.34M1.92%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Renee D. GalaPresident & CEO, Director140,3940.22%Nov 5, 2026
Patricia CarrSVP, Chief Accounting Officer6,5120.01%Nov 6, 2026
Neena M. PatilEVP & Chief Legal Officer47,6710.07%Sep 14, 2026
Mary Elizabeth HendersonSVP, Technical Operations23,8150.04%Sep 10, 2026
Robert IannoneEVP, Global Head of R&D & CMO112,1070.17%Aug 31, 2026
Samantha PearceEVP, Chief Commercial Officer47,1310.07%Aug 7, 2026
Philip L. JohnsonEVP & Chief Financial Officer56,4310.09%Jul 2, 2026
Bruce C. CozaddDirector357,5670.55%Nov 10, 2026
Patrick KennedyDirector8,2920.01%Sep 2, 2026
Laura HamillDirector8,5240.01%Sep 2, 2026
Norbert G. RiedelDirector17,5530.03%Sep 2, 2026
Heather Ann McSharryDirector18,1990.03%Sep 2, 2026
Mark Douglas SmithDirector9,5790.01%Sep 2, 2026
Ted W. LoveDirector2,3890.00%Sep 2, 2026
Rick E. WinninghamDirector9,4800.01%Sep 2, 2026
Patrick G. EnrightDirector21,2780.03%Sep 2, 2026
Jennifer E. CookDirector10,7360.02%Sep 2, 2026
Seamus MulliganDirector1,286,2541.98%Aug 7, 2026
Kenneth W. O'KeefeDirector30,2560.05%Dec 4, 2025
Anne ORiordanDirector16,5000.03%Aug 11, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Bruce C. Cozadd
Director
Nov 6, 2026Sale−5,923$237.39$1.41M357,567
Bruce C. Cozadd
Director
Nov 6, 2026Sale−24,483$236.84$5.80M363,490
Bruce C. Cozadd
Director
Nov 6, 2026Sale−10,688$235.82$2.52M387,973
Bruce C. Cozadd
Director
Nov 6, 2026Sale−27,714$234.91$6.51M398,661
Bruce C. Cozadd
Director
Nov 6, 2026Option exercise+85,766$136.18$11.68M426,375
Bruce C. Cozadd
Director
Nov 6, 2026Option exercise+734$136.18$99.96K340,609
Patricia Carr
SVP, Chief Accounting Officer
Nov 4, 2026Sale−163$231.27$37.70K6,512
Patricia Carr
SVP, Chief Accounting Officer
Nov 4, 2026Sale−1,250$231.37$289.21K6,675
Patricia Carr
SVP, Chief Accounting Officer
Nov 4, 2026Option exercise+1,250$140.03$175.04K7,925
Renee D. Gala
President & CEO, Director
Nov 3, 2026Sale(10b5-1 plan)−1,000$225.37$225.37K140,394
Bruce C. Cozadd
Director
Nov 2, 2026Sale(10b5-1 plan)−6,000$215.84$1.30M339,875
Renee D. Gala
President & CEO, Director
Oct 6, 2026Sale(10b5-1 plan)−2,000$236.40$472.80K141,394
Bruce C. Cozadd
Director
Oct 1, 2026Sale(10b5-1 plan)−6,000$230.33$1.38M345,875
Neena M. Patil
EVP & Chief Legal Officer
Sep 10, 2026Sale(10b5-1 plan)−1,200$240.94$289.13K47,671
Mary Elizabeth Henderson
SVP, Technical Operations
Sep 8, 2026Tax withholding−15$241.20$3.62K23,815
Mary Elizabeth Henderson
SVP, Technical Operations
Sep 8, 2026Tax withholding−1,412$243.03$343.16K23,830
Renee D. Gala
President & CEO
Sep 8, 2026Sale(10b5-1 plan)−2,000$243.03$486.06K143,394
Renee D. Gala
President & CEO
Sep 8, 2026Tax withholding−1,967$246.81$485.48K145,394
Bruce C. Cozadd
Director
Sep 1, 2026Sale(10b5-1 plan)−6,000$250.13$1.50M351,875
Mark Douglas Smith
Director
Aug 31, 2026Tax withholding−1,692$241.39$408.43K9,579
Mark Douglas Smith
Director
Aug 31, 2026Tax withholding−14$244.64$3.42K11,271
Ted W. Love
Director
Aug 31, 2026Tax withholding−737$241.39$177.90K2,389
Ted W. Love
Director
Aug 31, 2026Tax withholding−6$244.06$1.46K3,126
Rick E. Winningham
Director
Aug 31, 2026Tax withholding−1,692$241.39$408.43K9,480
Rick E. Winningham
Director
Aug 31, 2026Tax withholding−14$244.64$3.42K9,466
Mary Elizabeth Henderson
SVP, Technical Operations
Aug 31, 2026Tax withholding−16$244.64$3.91K25,242
Mary Elizabeth Henderson
SVP, Technical Operations
Aug 31, 2026Tax withholding−2,076$241.39$501.13K25,258
Bruce C. Cozadd
Director
Aug 31, 2026Tax withholding−1,209$241.39$291.84K357,875
Bruce C. Cozadd
Director
Aug 31, 2026Tax withholding−10$244.06$2.44K359,084
Patrick Kennedy
Director
Aug 31, 2026Tax withholding−15$244.06$3.66K8,292
Patrick Kennedy
Director
Aug 31, 2026Tax withholding−1,840$241.39$444.16K6,452
Jennifer E. Cook
Director
Aug 31, 2026Tax withholding−1,692$241.39$408.43K10,736
Jennifer E. Cook
Director
Aug 31, 2026Tax withholding−14$244.06$3.42K12,428
Patrick G. Enright
Director
Aug 31, 2026Tax withholding−1,692$241.39$408.43K21,278
Patrick G. Enright
Director
Aug 31, 2026Tax withholding−14$244.64$3.42K22,970
Laura Hamill
Director
Aug 31, 2026Tax withholding−14$244.06$3.42K8,524
Laura Hamill
Director
Aug 31, 2026Tax withholding−1,692$241.39$408.43K6,832
Norbert G. Riedel
Director
Aug 31, 2026Tax withholding−1,692$241.39$408.43K6,923
Norbert G. Riedel
Director
Aug 31, 2026Tax withholding−14$244.64$3.42K8,615
Heather Ann McSharry
Director
Aug 31, 2026Tax withholding−1,840$241.39$444.16K18,199
Heather Ann McSharry
Director
Aug 31, 2026Tax withholding−15$244.64$3.67K20,039
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Option exercise+884$113.10$99.98K112,107
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Option exercise+26,116$113.10$2.95M111,223
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Sale(10b5-1 plan)−19,639$250.60$4.92M75,245
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Sale(10b5-1 plan)−300$252.76$75.83K65,686
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Sale(10b5-1 plan)−9,259$251.95$2.33M65,986
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Sale(10b5-1 plan)−18,113$250.02$4.53M94,884
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Sale(10b5-1 plan)−11,423$248.67$2.84M112,997
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Sale(10b5-1 plan)−18,187$247.86$4.51M124,420
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Option exercise+2,916$137.12$399.84K142,607
Robert Iannone
EVP, Global Head of R&D & CMO
Aug 27, 2026Option exercise+27,584$137.12$3.78M139,691
Bruce C. Cozadd
Director
Aug 5, 2026Award+1,605––362,287
Seamus Mulligan
Director
Aug 5, 2026Award+1,605––1,184,633
Mark Douglas Smith
Director
Aug 5, 2026Award+1,605––11,285
Heather Ann McSharry
Director
Aug 5, 2026Award+1,605––20,054
Norbert G. Riedel
Director
Aug 5, 2026Award+1,605––8,629
Laura Hamill
Director
Aug 5, 2026Award+1,605––8,538
Patrick Kennedy
Director
Aug 5, 2026Award+1,605––8,307
Ted W. Love
Director
Aug 5, 2026Award+1,605––3,132
Patrick G. Enright
Director
Aug 5, 2026Award+1,605––22,984

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
9.25%
6M shares short
Days to cover
7.7
At 1M shares a day
Change since last report
-1.1%
From 6M shares
Short volume, 20 days
62.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Jazz Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 3,743 shares on Oct 5, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Bruce C. Cozadd
Director
Nov 6, 202668,808$16.24MNov 6, 2026Stock Option Exercise
Patricia Carr
Officer
Nov 4, 20261,413$326.91KNov 4, 2026Stock Option Exercise
Renee D. Gala
Officer, Director
Nov 3, 20261,000$225.37KNov 3, 2026Restricted Stock
Bruce C. Cozadd
Officer
Nov 2, 20266,000$1.30MNov 2, 2026Stock Option
Anne O'Riordan
Director
Oct 8, 202614,687$3.36MOct 8, 2026Stock Option Exercise
Renee D. Gala
Officer
Oct 6, 20262,000$472.80KOct 6, 2026Restricted Stock
Bruce C. Cozadd
Officer
Oct 1, 20266,000$1.38MOct 1, 2026Stock Option
Neena M. Patil
Officer
Sep 10, 20261,200$289.13KSep 10, 2026Restricted Stock
Renee D. Gala
Officer
Sep 8, 20262,000$486.06KSep 8, 2026Restricted Stock
Mary Elizabeth Henderson
Director
Sep 8, 20262,691$664.17KSep 8, 2026RESTRICTED STOCK VESTING
Bruce C. Cozadd
Officer
Sep 1, 20266,000$1.50MSep 1, 2026Stock Option
Jennifer E. Cook
Director
Aug 31, 20263,507$857.60KAug 31, 2026RESTRICTED STOCK VESTING
Heather Ann McSharry
Director
Aug 31, 20263,507$857.60KAug 31, 2026RESTRICTED STOCK VESTING
Bruce C. Cozadd
Director
Aug 31, 20262,506$612.82KAug 31, 2026RESTRICTED STOCK VESTING
Ted W. Love
Director
Aug 31, 20261,527$373.41KAug 31, 2026RESTRICTED STOCK VESTING

See a number that looks wrong?